WallStreetZenWallStreetZen

NASDAQ: XOMA
Xoma Royalty Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Xoma Royalty earnings were $16.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest XOMA earnings report on Sep 30, 2025 announced Q3 2025 earnings of $14.1M, up 154.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XOMA reported annual earnings of -$19.3M, with -58.3% growth. The next XOMA earnings date is Mar 5, 2026.

XOMA past earnings growth

How has XOMA's earnings growth performed historically?

Company
N/A
Industry
59.87%
Market
55.77%
XOMA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
XOMA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

XOMA earnings history

Current Revenue
$47.1M
Current Earnings
$16.6M
Current Profit Margin
35.2%

XOMA Return on Equity

Current Company
21.6%
Current Industry
-21.2%
Current Market
35.1%
XOMA's Return on Equity (20.3%)... subscribe to Premium to read more.
High Return on Equity Performance

XOMA Return on Assets

Current Company
7.2%
Current Industry
-8.8%
XOMA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XOMA announces earnings.

XOMA Return on Capital Employed

Current Company
10.39%
Current Industry
-3.5%
XOMA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XOMA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XOMA$26.75M$16.60M+43.69%$0.81
LRMR-$131.92M-$132.00MN/A-$1.94
AVIR-$145.78M-$147.03MN/A-$1.77
IMRX-$61.80M-$62.50MN/A-$1.79
RZLT-$76.61M-$77.18MN/A-$0.93
View Top Biotech Stocks

XOMA earnings dates

Next earnings date
Mar 5, 2026

Xoma Royalty Earnings Reports & History FAQ

What were Xoma Royalty's earnings last quarter?

On XOMA's earnings call on Invalid Date, Xoma Royalty (NASDAQ: XOMA) reported Q3 2025 earnings per share (EPS) of $0.74, up 146.54% year over year. Total XOMA earnings for the quarter were $14.05 million. In the same quarter last year, Xoma Royalty's earnings per share (EPS) was -$1.59.

If you're new to stock investing, here's how to buy Xoma Royalty stock.

When does Xoma Royalty report earnings?

The next XOMA earnings date is Invalid Date. Add XOMA to your watchlist to be reminded of Xoma Royalty's next earnings date.

Is Xoma Royalty profitable or losing money?

As of the last Xoma Royalty earnings report, Xoma Royalty is currently profitable. Xoma Royalty's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $16.60 million, a 144.77% decrease year over year.

What was XOMA's earnings growth in the past year?

As of Xoma Royalty's earnings date in Invalid Date, Xoma Royalty's earnings has grown year over year. XOMA earnings in the past year totalled $16.60 million.

What are Xoma Royalty's earnings expectations?

The current EPS estimate for Xoma Royalty's earnings report in Invalid Date is -$0.11.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.